Concepedia

Nicholas M. Dean

NM

Statistics

Publications

78

Citations

8.8K

H-Index

52

Active since

1987

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of South Alabama

National Institutes of Health

National Cancer Institute

Cancer Research Institute

Nicholas M. Dean is an author at Ionis Pharmaceuticals (United States) specializing in life sciences, molecular biology, and cell signaling.

Publications per year

1987–2013

78

Publications

78

MicroRNA-143 Regulates Adipocyte Differentiation

Christine Esau, Xiaolin Kang, Eigen Peralta et al. · Journal of Biological Chemistry · 2004 · 1K citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents

Timothy A. Vickers, Seongjoon Koo, C. Frank Bennett et al. · Journal of Biological Chemistry · 2003 · 460 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells

Sophie Derenne, Brett P. Monia, Nicholas M. Dean et al. · Blood · 2002 · 430 citations · Full text

Medicine, Cancer Biology, Cell Biology +10

Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity

Jeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent et al. · Journal of Clinical Investigation · 2007 · 379 citations · Full text

Medicine, Cancer Biology, Oncology +17

Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.

Nicholas M. Dean, Robert A. McKay, Thomas P. Condon et al. · Journal of Biological Chemistry · 1994 · 292 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +10

1–5 of 78